Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro
Akkermansia muciniphila is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of A. muciniphila to utilize human milk oligosac...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2020-08, Vol.10 (1), p.14330-14330, Article 14330 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 14330 |
---|---|
container_issue | 1 |
container_start_page | 14330 |
container_title | Scientific reports |
container_volume | 10 |
creator | Kostopoulos, Ioannis Elzinga, Janneke Ottman, Noora Klievink, Jay T. Blijenberg, Bernadet Aalvink, Steven Boeren, Sjef Mank, Marko Knol, Jan de Vos, Willem M. Belzer, Clara |
description | Akkermansia muciniphila
is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of
A. muciniphila
to utilize human milk oligosaccharides. We found that
A. muciniphila
was able to grow on human milk and degrade HMOs. Analyses of the proteome of
A. muciniphila
indicated that key-glycan degrading enzymes were expressed when the bacterium was grown on human milk. Our results display the functionality of the key-glycan degrading enzymes (α-
l
-fucosidases, β-galactosidases, exo-α-sialidases and β-acetylhexosaminidases) to degrade the HMO-structures 2′-FL, LNT, lactose, and LNT2. The hydrolysation of the host-derived glycan structures allows
A. muciniphila
to promote syntrophy with other beneficial bacteria, contributing in that way to a microbial ecological network in the gut. Thus, the capacity of
A. muciniphila
to utilize human milk will enable its survival in the early life intestine and colonization of the mucosal layer in early life, warranting later life mucosal and metabolic health. |
doi_str_mv | 10.1038/s41598-020-71113-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7459334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2439624252</sourcerecordid><originalsourceid>FETCH-LOGICAL-c577t-713b6b4367756847ea41de572553f6f4a32a8f843d8d3b710f8a8e6cb7a38a423</originalsourceid><addsrcrecordid>eNp1UU1r3DAQFSWlCWn-QA9BkEsuTq0vS74EQmibQqCX9ixkebxWVpY2kr2Qfx9tNw2bQuYyA-_Nm3k8hL6Q-orUTH3NnIhWVTWtK0kIYZX6gE5ozUVFGaVHB_MxOsv5oS4laMtJ-wkdM6oapVh7gsab9RrSZEJ2Bk-LdcFtRucNXjJkPC4FwZPzaxy9W8VsrB1Ncn3B5ojnMbktYBfKBBhM8k_YuwGwjaF3s4sh78Ctm1P8jD4Oxmc4e-mn6M_3b79v76r7Xz9-3t7cV1ZIORcvrGs6zhopRaO4BMNJD0JSIdjQDNwwatSgOOtVzzpJ6kEZBY3tpGHKcMpO0fVed7N0E_QWwpyM15vkJpOedDROv0WCG_UqbrXkomWMF4HLF4EUHxfIs55ctuC9CRCXrClnbUM5FbtbF_9RH-KSQrGniVKyIURyUlh0z7Ip5pxgeH2G1HqXpd5nqUuW-m-WWpWl80Mbryv_kisEtifkAoUVpIPb78s-A0CBq0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1887611741</pqid></control><display><type>article</type><title>Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro</title><source>MEDLINE</source><source>Nature Free</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature OA Free Journals</source><creator>Kostopoulos, Ioannis ; Elzinga, Janneke ; Ottman, Noora ; Klievink, Jay T. ; Blijenberg, Bernadet ; Aalvink, Steven ; Boeren, Sjef ; Mank, Marko ; Knol, Jan ; de Vos, Willem M. ; Belzer, Clara</creator><creatorcontrib>Kostopoulos, Ioannis ; Elzinga, Janneke ; Ottman, Noora ; Klievink, Jay T. ; Blijenberg, Bernadet ; Aalvink, Steven ; Boeren, Sjef ; Mank, Marko ; Knol, Jan ; de Vos, Willem M. ; Belzer, Clara</creatorcontrib><description>Akkermansia muciniphila
is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of
A. muciniphila
to utilize human milk oligosaccharides. We found that
A. muciniphila
was able to grow on human milk and degrade HMOs. Analyses of the proteome of
A. muciniphila
indicated that key-glycan degrading enzymes were expressed when the bacterium was grown on human milk. Our results display the functionality of the key-glycan degrading enzymes (α-
l
-fucosidases, β-galactosidases, exo-α-sialidases and β-acetylhexosaminidases) to degrade the HMO-structures 2′-FL, LNT, lactose, and LNT2. The hydrolysation of the host-derived glycan structures allows
A. muciniphila
to promote syntrophy with other beneficial bacteria, contributing in that way to a microbial ecological network in the gut. Thus, the capacity of
A. muciniphila
to utilize human milk will enable its survival in the early life intestine and colonization of the mucosal layer in early life, warranting later life mucosal and metabolic health.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-020-71113-8</identifier><identifier>PMID: 32868839</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/326 ; 631/326/2565/2134 ; 631/326/2565/855 ; Akkermansia - enzymology ; Akkermansia - growth & development ; Fibroblast growth factor 2 ; Glycoside Hydrolases - metabolism ; Growth factors ; Humanities and Social Sciences ; Humans ; Milk ; Milk, Human - microbiology ; Mucus - metabolism ; multidisciplinary ; Oligosaccharides - metabolism ; Patients ; Periodontal diseases ; Periodontium ; Platelet-derived growth factor ; Platelet-derived growth factor BB ; Probiotics ; Regeneration ; Science ; Science (multidisciplinary) ; Systematic review ; Therapeutic applications</subject><ispartof>Scientific reports, 2020-08, Vol.10 (1), p.14330-14330, Article 14330</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c577t-713b6b4367756847ea41de572553f6f4a32a8f843d8d3b710f8a8e6cb7a38a423</citedby><cites>FETCH-LOGICAL-c577t-713b6b4367756847ea41de572553f6f4a32a8f843d8d3b710f8a8e6cb7a38a423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459334/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459334/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32868839$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kostopoulos, Ioannis</creatorcontrib><creatorcontrib>Elzinga, Janneke</creatorcontrib><creatorcontrib>Ottman, Noora</creatorcontrib><creatorcontrib>Klievink, Jay T.</creatorcontrib><creatorcontrib>Blijenberg, Bernadet</creatorcontrib><creatorcontrib>Aalvink, Steven</creatorcontrib><creatorcontrib>Boeren, Sjef</creatorcontrib><creatorcontrib>Mank, Marko</creatorcontrib><creatorcontrib>Knol, Jan</creatorcontrib><creatorcontrib>de Vos, Willem M.</creatorcontrib><creatorcontrib>Belzer, Clara</creatorcontrib><title>Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Akkermansia muciniphila
is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of
A. muciniphila
to utilize human milk oligosaccharides. We found that
A. muciniphila
was able to grow on human milk and degrade HMOs. Analyses of the proteome of
A. muciniphila
indicated that key-glycan degrading enzymes were expressed when the bacterium was grown on human milk. Our results display the functionality of the key-glycan degrading enzymes (α-
l
-fucosidases, β-galactosidases, exo-α-sialidases and β-acetylhexosaminidases) to degrade the HMO-structures 2′-FL, LNT, lactose, and LNT2. The hydrolysation of the host-derived glycan structures allows
A. muciniphila
to promote syntrophy with other beneficial bacteria, contributing in that way to a microbial ecological network in the gut. Thus, the capacity of
A. muciniphila
to utilize human milk will enable its survival in the early life intestine and colonization of the mucosal layer in early life, warranting later life mucosal and metabolic health.</description><subject>631/326</subject><subject>631/326/2565/2134</subject><subject>631/326/2565/855</subject><subject>Akkermansia - enzymology</subject><subject>Akkermansia - growth & development</subject><subject>Fibroblast growth factor 2</subject><subject>Glycoside Hydrolases - metabolism</subject><subject>Growth factors</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Milk</subject><subject>Milk, Human - microbiology</subject><subject>Mucus - metabolism</subject><subject>multidisciplinary</subject><subject>Oligosaccharides - metabolism</subject><subject>Patients</subject><subject>Periodontal diseases</subject><subject>Periodontium</subject><subject>Platelet-derived growth factor</subject><subject>Platelet-derived growth factor BB</subject><subject>Probiotics</subject><subject>Regeneration</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Systematic review</subject><subject>Therapeutic applications</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1UU1r3DAQFSWlCWn-QA9BkEsuTq0vS74EQmibQqCX9ixkebxWVpY2kr2Qfx9tNw2bQuYyA-_Nm3k8hL6Q-orUTH3NnIhWVTWtK0kIYZX6gE5ozUVFGaVHB_MxOsv5oS4laMtJ-wkdM6oapVh7gsab9RrSZEJ2Bk-LdcFtRucNXjJkPC4FwZPzaxy9W8VsrB1Ncn3B5ojnMbktYBfKBBhM8k_YuwGwjaF3s4sh78Ctm1P8jD4Oxmc4e-mn6M_3b79v76r7Xz9-3t7cV1ZIORcvrGs6zhopRaO4BMNJD0JSIdjQDNwwatSgOOtVzzpJ6kEZBY3tpGHKcMpO0fVed7N0E_QWwpyM15vkJpOedDROv0WCG_UqbrXkomWMF4HLF4EUHxfIs55ctuC9CRCXrClnbUM5FbtbF_9RH-KSQrGniVKyIURyUlh0z7Ip5pxgeH2G1HqXpd5nqUuW-m-WWpWl80Mbryv_kisEtifkAoUVpIPb78s-A0CBq0A</recordid><startdate>20200831</startdate><enddate>20200831</enddate><creator>Kostopoulos, Ioannis</creator><creator>Elzinga, Janneke</creator><creator>Ottman, Noora</creator><creator>Klievink, Jay T.</creator><creator>Blijenberg, Bernadet</creator><creator>Aalvink, Steven</creator><creator>Boeren, Sjef</creator><creator>Mank, Marko</creator><creator>Knol, Jan</creator><creator>de Vos, Willem M.</creator><creator>Belzer, Clara</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200831</creationdate><title>Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro</title><author>Kostopoulos, Ioannis ; Elzinga, Janneke ; Ottman, Noora ; Klievink, Jay T. ; Blijenberg, Bernadet ; Aalvink, Steven ; Boeren, Sjef ; Mank, Marko ; Knol, Jan ; de Vos, Willem M. ; Belzer, Clara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c577t-713b6b4367756847ea41de572553f6f4a32a8f843d8d3b710f8a8e6cb7a38a423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>631/326</topic><topic>631/326/2565/2134</topic><topic>631/326/2565/855</topic><topic>Akkermansia - enzymology</topic><topic>Akkermansia - growth & development</topic><topic>Fibroblast growth factor 2</topic><topic>Glycoside Hydrolases - metabolism</topic><topic>Growth factors</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Milk</topic><topic>Milk, Human - microbiology</topic><topic>Mucus - metabolism</topic><topic>multidisciplinary</topic><topic>Oligosaccharides - metabolism</topic><topic>Patients</topic><topic>Periodontal diseases</topic><topic>Periodontium</topic><topic>Platelet-derived growth factor</topic><topic>Platelet-derived growth factor BB</topic><topic>Probiotics</topic><topic>Regeneration</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Systematic review</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kostopoulos, Ioannis</creatorcontrib><creatorcontrib>Elzinga, Janneke</creatorcontrib><creatorcontrib>Ottman, Noora</creatorcontrib><creatorcontrib>Klievink, Jay T.</creatorcontrib><creatorcontrib>Blijenberg, Bernadet</creatorcontrib><creatorcontrib>Aalvink, Steven</creatorcontrib><creatorcontrib>Boeren, Sjef</creatorcontrib><creatorcontrib>Mank, Marko</creatorcontrib><creatorcontrib>Knol, Jan</creatorcontrib><creatorcontrib>de Vos, Willem M.</creatorcontrib><creatorcontrib>Belzer, Clara</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kostopoulos, Ioannis</au><au>Elzinga, Janneke</au><au>Ottman, Noora</au><au>Klievink, Jay T.</au><au>Blijenberg, Bernadet</au><au>Aalvink, Steven</au><au>Boeren, Sjef</au><au>Mank, Marko</au><au>Knol, Jan</au><au>de Vos, Willem M.</au><au>Belzer, Clara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2020-08-31</date><risdate>2020</risdate><volume>10</volume><issue>1</issue><spage>14330</spage><epage>14330</epage><pages>14330-14330</pages><artnum>14330</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Akkermansia muciniphila
is a well-studied anaerobic bacterium specialized in mucus degradation and associated with human health. Because of the structural resemblance of mucus glycans and free human milk oligosaccharides (HMOs), we studied the ability of
A. muciniphila
to utilize human milk oligosaccharides. We found that
A. muciniphila
was able to grow on human milk and degrade HMOs. Analyses of the proteome of
A. muciniphila
indicated that key-glycan degrading enzymes were expressed when the bacterium was grown on human milk. Our results display the functionality of the key-glycan degrading enzymes (α-
l
-fucosidases, β-galactosidases, exo-α-sialidases and β-acetylhexosaminidases) to degrade the HMO-structures 2′-FL, LNT, lactose, and LNT2. The hydrolysation of the host-derived glycan structures allows
A. muciniphila
to promote syntrophy with other beneficial bacteria, contributing in that way to a microbial ecological network in the gut. Thus, the capacity of
A. muciniphila
to utilize human milk will enable its survival in the early life intestine and colonization of the mucosal layer in early life, warranting later life mucosal and metabolic health.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32868839</pmid><doi>10.1038/s41598-020-71113-8</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2020-08, Vol.10 (1), p.14330-14330, Article 14330 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7459334 |
source | MEDLINE; Nature Free; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry; Springer Nature OA Free Journals |
subjects | 631/326 631/326/2565/2134 631/326/2565/855 Akkermansia - enzymology Akkermansia - growth & development Fibroblast growth factor 2 Glycoside Hydrolases - metabolism Growth factors Humanities and Social Sciences Humans Milk Milk, Human - microbiology Mucus - metabolism multidisciplinary Oligosaccharides - metabolism Patients Periodontal diseases Periodontium Platelet-derived growth factor Platelet-derived growth factor BB Probiotics Regeneration Science Science (multidisciplinary) Systematic review Therapeutic applications |
title | Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T16%3A32%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Akkermansia%20muciniphila%20uses%20human%20milk%20oligosaccharides%20to%20thrive%20in%20the%20early%20life%20conditions%20in%20vitro&rft.jtitle=Scientific%20reports&rft.au=Kostopoulos,%20Ioannis&rft.date=2020-08-31&rft.volume=10&rft.issue=1&rft.spage=14330&rft.epage=14330&rft.pages=14330-14330&rft.artnum=14330&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-020-71113-8&rft_dat=%3Cproquest_pubme%3E2439624252%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1887611741&rft_id=info:pmid/32868839&rfr_iscdi=true |